Skip to content

Nalbuphine suppresses fentanyl-induced cough during general anesthesia induction in children: a prospective, randomized controlled study

Nalbuphine suppresses fentanyl-induced cough during general anesthesia induction in children: a prospective, randomized controlled stud

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056634
Enrollment
Unknown
Registered
2022-02-09
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scheduled for elective surgery under general anesthesia

Interventions

experimental group:Intravenous nalbuphine 5 µg/kg
control group:Intravenous lidocaine1 mg/kg

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.ASA score I or II; 2.aged 2-12 years; 3.scheduled for elective surgery under general anesthesia with endotracheal intubation; 4.No previous history of systemic disease; 5.provide informed consent.

Exclusion criteria

Exclusion criteria: 1.body weight exceeding 20% of the ideal body weight; 2.hepatic and renal dysfunction,and history of other systemic diseases; 3.a history of upper respiratory tract infection and cough within the previous 2 weeks; 4.a history of asthma; 5.Recent use of medications that could affect the study,such as angiotensin converting enzyme inhibitors, antidepressants,bronchodilators, or steroids.

Design outcomes

Primary

MeasureTime frame
The incidence of cough;

Countries

China

Contacts

Public ContactYing Sun

Department of Anesthesiology, Shanghai Children's Medical Center

yingsun821@163.com+86 13621738118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026